GLP-1 drugs, widely used for treating metabolic disorders, often face issues with long term tolerability, leading to side effects such as sarcopenia and bone density loss. These complications ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its ...

Naturally, more work is needed. Although GLS -1 agonists have been used in diabetes for 20 years, some of the newer findings ...

Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

New analysis from GlobalData spans the growth of the heart failure market across seven major markets including the US, Europe ...

More obesity drugs are being launched this year following Novo Nordisk and Eli Lilly's previous successes with GLP-1 drugs.

A recent breakthrough in medical research offers exciting possibilities for people dealing with diabetes and obesity. This ...

Clarivate identifies eleven potential blockbuster and transformative drugs in annual Drugs to Watch report: London, UK Friday, January 10, 2025, 14:00 Hrs [IST] Clarivate Plc, a l ...

Sharon Mann has lost nearly 30 pounds since starting on Mounjaro, a GLP-1 medication. Dr. Sanjay Gupta reports.

As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...

As usage of the medications increases, Circana research indicates deli and produce could be bright spots for spending.

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...